Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Amanda N. Ruggieri
Observed names:
Amanda Ruggieri,
Amanda Ruggieri-Joyce
Observed institutions:
Johns Hopkins University,
Emory University,
Johns Hopkins Medicine,
Sidney Kimmel Cancer Center,
Sidney Kimmel Comprehensive Cancer Center,
Winship Cancer Institute
show all 6
ORCID:
0000-0003-1005-9607
Observed ORCID:
0000-0003-1005-9607
OpenAlex ID:
A5027603143
Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer
2023
·
Mehmet Akce
, Batoul Farran
, et al.
·
Journal for ImmunoTherapy of Cancer
·
52
PDF
Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer
2020
·
Yuchen Zhang
, Michael B. Ware
, et al.
·
Molecular Cancer Therapeutics
·
50
MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity
2019
·
Mark Yarchoan
, Aditya A. Mohan
, et al.
·
PLoS ONE
·
45
PDF
Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell– and CXCR3-dependent manner
2023
·
Michael Brandon Ware
, Maggie Phillips
, et al.
·
JCI Insight
·
40
PDF
Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy
2021
·
Lauren Dennison
, Amanda Ruggieri
, et al.
·
Cancer Immunology Research
·
24
Expression of tdTomato and luciferase in a murine lung cancer alters the growth and immune microenvironment of the tumor
2021
·
Lei Huang
, Ramireddy Bommireddy
, et al.
·
PLoS ONE
·
20
PDF
Abstract CT043: A multicenter randomized phase 2 trial of atezolizumab as monotherapy or in combination with cobimetinib in biliary tract cancers (BTCs): A NCI Experimental Therapeutics Clinical Trials Network (ETCTN) study
2020
·
Mark Yarchoan
, Leslie Cope
, et al.
·
Cancer Research
·
17
Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer
2022
·
Amanda N. Ruggieri
, Mark Yarchoan
, et al.
·
Clinical Cancer Research
·
14
Suppressive myeloid cells are expanded by biliary tract cancer-derived cytokines in vitro and associate with aggressive disease
2020
·
Michael B. Ware
, Mohammad Y. Zaidi
, et al.
·
British Journal of Cancer
·
10
PDF
Optical Control of Cytokine Signaling via Bioinspired, Polymer-Induced Latency
2020
·
Lacey A. Perdue
, Priscilla Do
, et al.
·
Biomacromolecules
·
6
PDF
Dual blockade of IL-6 and CTLA-4 regresses pancreatic tumors in a CD4 + T cell-dependent manner
2020
·
Michael Brandon Ware
, Christopher McQuinn
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
4
PDF
Dual blockade of IL-6 and CTLA-4 regresses pancreatic tumors in a CD4+ T-cell-dependent manner.
2021
·
Michael Ware
, Christopher McQuinn
, et al.
·
Research Square
·
2
PDF
Abstract 3482: Correlative analysis of metformin and nivolumab combination in treatment-refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC)
2022
·
Batoul Farran
, Jeffrey M. Switchenko
, et al.
·
Cancer Research
·
1
Correction: Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer
2026
·
Yuchen Zhang
, Michael B. Ware
, et al.
·
Molecular Cancer Therapeutics
Data from Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy
2023
·
Lauren Dennison
, Amanda Ruggieri
, et al.
Supplementary Data from Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy
2023
·
Lauren Dennison
, Amanda Ruggieri
, et al.
Supplementary Data from Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy
2023
·
Lauren Dennison
, Amanda Ruggieri
, et al.
Data from Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy
2023
·
Lauren Dennison
, Amanda Ruggieri
, et al.
Supplementary Data from Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer
2023
·
Yuchen Zhang
, Michael B. Ware
, et al.
Data from Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer
2023
·
Yuchen Zhang
, Michael B. Ware
, et al.
Data from Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer
2023
·
Yuchen Zhang
, Michael B. Ware
, et al.
Supplementary Data from Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer
2023
·
Yuchen Zhang
, Michael B. Ware
, et al.
PDF
Data from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer
2023
·
Amanda N. Ruggieri
, Mark Yarchoan
, et al.
Supplementary Table from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer
2023
·
Amanda N. Ruggieri
, Mark Yarchoan
, et al.
Supplementary Table from Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer
2023
·
Amanda N. Ruggieri
, Mark Yarchoan
, et al.
Show more works
View as search
Works count:
47
Citation count:
285
H-index:
9
I10-index:
9
Year
Topic
Type
